FDA Adverse Event Electronic Reporting Delayed To Complete Portal Roll-Out
This article was originally published in The Pink Sheet Daily
Executive Summary
Because some submitters will not have enough time to register for new electronic submission system, FDA will continue accepting paper post-marketing safety reports a little longer.